Philippe Connes Selected Research

Sickle Cell Trait

1/2019	Evaluation of agreement between hemoglobin A1c, fasting glucose, and fructosamine in Senegalese individuals with and without sickle-cell trait.
2/2018	Does physical activity increase or decrease the risk of sickle cell disease complications?
5/2016	Role of Exercise-Induced Oxidative Stress in Sickle Cell Trait and Disease.
11/2013	Intraday blood rheological changes induced by Ramadan fasting in sickle cell trait carriers.
1/2013	Exercise-related complications in sickle cell trait.
1/2012	Moderate endurance exercise is not a risk for rhabdomyolysis or renal failure in sickle cell trait carriers.
1/2010	Red blood cell deformability and aggregation, cell adhesion molecules, oxidative stress and nitric oxide markers after a short term, submaximal, exercise in sickle cell trait carriers.
12/2008	Effects of strenuous exercise on autonomic nervous system activity in sickle cell trait carriers.
1/2008	Plasma levels of adhesion molecules ICAM-1 and VCAM-1 in athletes with sickle cell trait with or without alpha-thalassemia during endurance exercise and recovery.
1/2008	Effects of strenuous exercise on blood coagulation activity in sickle cell trait carriers.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Philippe Connes Research Topics

Disease

48	Sickle Cell Anemia (Hemoglobin S Disease) 11/2022 - 01/2008
15	Sickle Cell Trait 01/2019 - 12/2005
11	Hemolysis 11/2022 - 05/2013
9	Inflammation (Inflammations) 06/2021 - 01/2013
8	Hemoglobin SC Disease (Disease, Hemoglobin SC) 06/2021 - 01/2014
7	alpha-Thalassemia 01/2022 - 07/2005
7	Hypoxia (Hypoxemia) 01/2022 - 09/2004
6	Anemia 01/2022 - 01/2013
6	Acute Chest Syndrome 01/2020 - 01/2013
5	Thalassemia 12/2018 - 01/2014
3	Pain (Aches) 01/2022 - 11/2011
3	Glucosephosphate Dehydrogenase Deficiency 09/2020 - 03/2017
3	Hypertension (High Blood Pressure) 12/2018 - 01/2013
3	Hemoglobinopathies 01/2017 - 01/2008
2	Inborn Genetic Diseases (Disease, Hereditary) 01/2021 - 01/2020
2	Macular Degeneration (Age-Related Maculopathy) 01/2021 - 12/2019
2	Vascular Diseases (Vascular Disease) 01/2021 - 01/2018
2	Dehydration (Water Stress) 01/2020 - 01/2019
1	Atrophy 11/2022
1	Stroke (Strokes) 02/2022
1	Infections 01/2021
1	Ischemia 01/2021
1	Hemorrhage 11/2020
1	Thrombophilia 11/2020
1	Atherosclerotic Plaque (Atheroma) 04/2020
1	Carotid Stenosis (Carotid Artery Stenosis) 04/2020
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Fibrosis (Cirrhosis) 01/2019
1	Hyperglycemia 01/2019
1	Kidney Diseases (Kidney Disease) 01/2019
1	Peripheral Nervous System Diseases (PNS Diseases) 12/2018
1	Peripheral Arterial Disease 12/2018
1	Osteonecrosis (Kienbock's Disease) 03/2018
1	Abdominal Obesity 03/2018
1	Cholelithiasis 03/2017
1	Disease Progression 01/2017
1	Brain Hypoxia (Cerebral Hypoxia) 01/2017
1	Leukocytosis (Pleocytosis) 11/2016
1	Cardiomegaly (Heart Hypertrophy) 11/2016

Drug/Important Bio-Agent (IBA)

25	Hemoglobins (Hemoglobin)IBA 01/2021 - 11/2007
13	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021 - 01/2010
11	Oxygen (Dioxygen)IBA 01/2022 - 08/2009
9	Biological ProductsIBA 02/2022 - 08/2010
9	Hydroxyurea (Hydrea)FDA LinkGeneric 06/2021 - 10/2015
6	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2015
6	Sickle HemoglobinIBA 01/2021 - 08/2009
4	GlobinsIBA 01/2021 - 01/2011
4	alpha-GlobinsIBA 01/2021 - 08/2010
3	Fetal Hemoglobin (Hemoglobin F)IBA 01/2022 - 01/2013
3	CytokinesIBA 01/2021 - 01/2018
3	AntioxidantsIBA 09/2020 - 05/2016
3	LipidsIBA 04/2020 - 01/2013
3	Advanced Glycation End ProductsIBA 01/2019 - 11/2015
3	Nitric Oxide Synthase (NO Synthase)IBA 12/2018 - 02/2015
3	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 11/2016 - 01/2007
2	SelectinsIBA 01/2022 - 01/2008
2	Hemoglobin CIBA 05/2021 - 06/2014
2	Biological FactorsIBA 01/2021 - 01/2013
2	Advanced Oxidation Protein Products (AOPP)IBA 09/2020 - 11/2016
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2019
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 05/2016
2	hemoglobin AAIBA 12/2019 - 07/2005
2	Triglycerides (Triacylglycerol)IBA 03/2018 - 01/2013
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2008 - 01/2007
2	Lactic Acid (Lactate)FDA LinkGeneric 02/2006 - 09/2004
1	Retinaldehyde (Retinal)IBA 11/2022
1	P-SelectinIBA 01/2022
1	lysophosphatidic acidIBA 01/2021
1	Edetic Acid (EDTA)FDA Link 01/2021
1	Hemostatics (Antihemorrhagics)IBA 11/2020
1	CalciumIBA 04/2020
1	Antigen Receptors (Antigen Receptor)IBA 01/2020
1	Heme (Haem)IBA 01/2020
1	CholesterolIBA 01/2020
1	ChemokinesIBA 01/2020
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	PhosphatidylserinesIBA 01/2020
1	AlarminsIBA 01/2020
1	Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA 01/2020
1	C-Reactive ProteinIBA 10/2019
1	DiamideIBA 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2019
1	IronIBA 01/2019
1	FructosamineIBA 01/2019
1	NitritesIBA 12/2018
1	Morphine (MS Contin)FDA LinkGeneric 07/2018
1	Opioid Analgesics (Opioids)IBA 07/2018
1	BilirubinIBA 07/2018
1	HDL CholesterolIBA 03/2018
1	beta-Globins (beta Globin)IBA 01/2018
1	3-nitrotyrosineIBA 01/2018
1	Messenger RNA (mRNA)IBA 11/2016
1	Pharmaceutical PreparationsIBA 11/2016

Therapy/Procedure

8	Therapeutics 06/2021 - 01/2014
2	Aftercare (After-Treatment) 03/2015 - 12/2012
1	Blood Transfusion (Blood Transfusions) 11/2020
1	Carotid Endarterectomy 04/2020
1	Plasmapheresis 11/2017